Advances in Mucin Research

Dear Colleagues,

On behalf of the Journal of Clinical Medicine (JCM) Editorial Team, we are delighted to present a new Special Issue on the topic of “Mucins”, Guest Edited by Dr. Christopher Campbell, from Adventist University of Health Sciences in Orlando, Florida.

Mucins are an important immunomodulatory component of the mucous membranes throughout the body. They are characterized by their large polymorphic central domain with tandem repeats rich in serine, threonine, and proline residues. They are the most abundant high molecular weight glycoprotein in mucus and prevent infection by vast numbers of microorganisms. Of the several immunological mechanisms in place to protect mucosal linings from their own microbiota, mucins of the mucous membrane aid in preventing translocation of bacteria to the underlying tissue. In recent years, research has highlighted the role these glycoproteins in cancer diagnosis and therapy. The secreted and transmembrane mucins have been previously found to be involved with inflammation and cancer. Additionally, mucins have demonstrated clinical significance in cystic fibrosis, asthma, and other muco-obstructive airway diseases. Consequently, mucins have been identified as potential therapeutic targets. This Special Issue aims to examine the advances in mucin research, and broaden our understanding of their role in human biology.

Dr. Christopher Campbell
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.